Skip to content
The Nexus
DossierENTITY

Efluelda

Coverage of Efluelda in the Nexus archive.

Earliest in view: Jun 26 · 12:29 UTCMost recent: Jun 26 · 12:29 UTC
Co-mentioned in this coverage
Sanofiorganization1European Commissionorganization1CSL Seqirusorganization1Fluadproduct1Germanyplace1Franceplace1Influenzatopic1
Recent coverage
  • HEALTHJun 26 · 12:29 UTCSTAT NEWS
    STAT+: European antitrust regulators probe Sanofi for allegedly disparaging a rival flu vaccine

    The European Commission is investigating Sanofi for allegedly violating antitrust rules by running a misleading campaign that disparages CSL Seqirus's Fluad vaccine, portraying it as inferior to Sanofi's Efluelda vaccine. The campaign targeted healthcare professionals in Germany and France, where Sanofi holds a dominant market position, and contradicted national vaccine recommendations in several EU member states.